Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03328182 · ClinicalTrials.gov registry record · NA

Assessment of an Oral Endotracheal Subglottic Tube Holder

A NA study of Intubation, sponsored by Hollister Incorporated.

Completed
Registry status
NA
Development phase
34
Enrollment target
4
Study locations

NCT03328182 is a NA study of Intubation that has completed, run by Hollister Incorporated. The registered enrollment target is 34 participants, below the 2,873-participant average among 4 other Intubation trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03328182, a NA study of Intubation, has completed, sponsored by Hollister Incorporated.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target
4
Study locations

Study Summary

This study is designed to assess the acceptability and usability of a new Endotracheal Tube (ET) holding device for an orally intubated patient.

Conditions Studied

Interventions

  • DEVICE New oral endotracheal tube holder

Study Locations (4)

Oregon

  • Legacy Mount Hood Medical Center - Gresham
  • Legacy Good Samaritan Medical Center - Portland
  • Legacy Emanuel Hospital & Health Center - Portland

California

  • Community Regional Medical Center - Fresno

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2017-10-23
Est. Completion 2018-06-15
Phase NA

Sponsor

Hollister Incorporated

11 total trials

What the Registry Record Tells You About NCT03328182

The ClinicalTrials.gov registry entry for NCT03328182 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,873-participant average among 4 other Intubation trials with a reported enrollment target (99% lower). The listed sponsor is Hollister Incorporated, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Intubation appearing as the primary indexed condition, and to 1 intervention - of which New oral endotracheal tube holder is the first listed.

NCT03328182 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Oregon, California.

Frequently Asked Questions

What is clinical trial NCT03328182 about?

NCT03328182 is a clinical study titled "Assessment of an Oral Endotracheal Subglottic Tube Holder". This study is designed to assess the acceptability and usability of a new Endotracheal Tube (ET) holding device for an orally intubated patient.

What is the current status of trial NCT03328182?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2017-10-23. Estimated completion is 2018-06-15.

What conditions does trial NCT03328182 study?

This clinical trial studies the following conditions: Intubation.

What interventions are being tested in trial NCT03328182?

The interventions under investigation include: New oral endotracheal tube holder (DEVICE).

Who is sponsoring clinical trial NCT03328182?

This trial is sponsored by Hollister Incorporated, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03328182 being conducted?

This trial has 4 study locations across California, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intubation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.